Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase

被引:222
作者
Cohen, Miriam [1 ]
Zhang, Xing-Quan [2 ]
Senaati, Hooman P. [1 ]
Chen, Hui-Wen [2 ]
Varki, Nissi M. [1 ]
Schooley, Robert T. [2 ]
Gagneux, Pascal [1 ]
机构
[1] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Div Infect Dis, La Jolla, CA 92093 USA
来源
VIROLOGY JOURNAL | 2013年 / 10卷
关键词
Influenza A; Sialic acids; Mucus; Neuraminidase; Infection; Saliva; HUMAN AIRWAY EPITHELIUM; HUMAN SALIVARY MUCINS; RECEPTOR-BINDING; VIRUS INFECTION; RESPIRATORY-TRACT; MEMBRANE-FUSION; SPECIFICITY; MICROARRAY; CONTRIBUTE; DEFENSE;
D O I
10.1186/1743-422X-10-321
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Influenza A virus (IAV) neuraminidase (NA) cleaves sialic acids (Sias) from glycans. Inhibiting NA with oseltamivir suppresses both viral infection, and viral release from cultured human airway epithelial cells. The role of NA in viral exit is well established: it releases budding virions by cleaving Sias from glycoconjugates on infected cells and progeny virions. The role of NA in viral entry remains unclear. Host respiratory epithelia secrete a mucus layer rich in heavily sialylated glycoproteins; these could inhibit viral entry by mimicking sialylated receptors on the cell surface. It has been suggested that NA allows influenza to penetrate the mucus by cleaving these sialylated decoys, but the exact mechanism is not yet established. Methods: We tested IAV interaction with secreted mucus using frozen human trachea/bronchus tissue sections, and bead-bound purified human salivary mucins (HSM) and purified porcine submaxillary mucins (PSM). The protective effect of mucus was analyzed using MDCK cells coated with purified HSM and PSM with known Sia content. Oseltamivir was used to inhibit NA activity, and the fluorescent reporter substrate, 4MU-Neu5Ac, was used to quantify NA activity. Results: IAV binds to the secreted mucus layer of frozen human trachea/bronchus tissues in a Sia dependent manner. HSM inhibition of IAV infection is Sia dose-dependent, but PSM cannot inhibit infection of underlying cells. HSM competitively inhibits NA cleavage of 4MU-Neu5Ac, reporter substrate. Human IAV effectively cleaves Sias from HSM but not from PSM, and binds to HSM but not to PSM. Conclusion: IAV interacts with human mucus on frozen tissue sections and mucus-coated beads. Inhibition of IAV infection by sialylated human mucus is dose-dependent, and enhanced when NA is inhibited with oseltamivir. Thus NA cleaves sialylated decoys during initial stages of infection. Understanding IAV interactions with host mucins is a promising new avenue for drug development.
引用
收藏
页数:13
相关论文
共 52 条
  • [1] NOMENCLATURE OF VIRUSES
    ANDREWES, CH
    [J]. NATURE, 1954, 173 (4405) : 620 - 621
  • [2] Chemical diversity in the sialic acids and related α-keto acids:: An evolutionary perspective
    Angata, T
    Varki, A
    [J]. CHEMICAL REVIEWS, 2002, 102 (02) : 439 - 469
  • [3] Metabolism of Vertebrate Amino Sugars with N-Glycolyl Groups MECHANISMS UNDERLYING GASTROINTESTINAL INCORPORATION OF THE NON-HUMAN SIALIC ACID XENO-AUTOANTIGEN N-GLYCOLYLNEURAMINIC ACID
    Banda, Kalyan
    Gregg, Christopher J.
    Chow, Renee
    Varki, Nissi M.
    Varki, Ajit
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (34) : 28852 - 28864
  • [4] MUCOPROTEINS IN RELATION TO VIRUS ACTION
    BURNET, FM
    [J]. PHYSIOLOGICAL REVIEWS, 1951, 31 (02) : 131 - 150
  • [5] Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray
    Childs, Robert A.
    Palma, Angelina S.
    Wharton, Steve
    Matrosovich, Tatyana
    Liu, Yan
    Chai, Wengang
    Campanero-Rhodes, Maria A.
    Zhang, Yibing
    Eickmann, Markus
    Kiso, Makoto
    Hay, Alan
    Matrosovich, Mikhail
    Feizi, Ten
    [J]. NATURE BIOTECHNOLOGY, 2009, 27 (09) : 797 - 799
  • [6] Using Unfixed, Frozen Tissues to Study Natural Mucin Distribution
    Cohen, Miriam
    Varki, Nissi M.
    Jankowski, Mark D.
    Gagneux, Pascal
    [J]. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2012, (67):
  • [7] Barrier properties of mucus
    Cone, Richard A.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (02) : 75 - 85
  • [8] Influenza virus infection: don't forget the role of the mucociliary system!
    Duez, Jean-Marie
    Sixt, Nathalie
    Pechinot, Andre
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (02) : 421 - 422
  • [9] MEDICAL PROGRESS Airway Mucus Function and Dysfunction
    Fahy, John V.
    Dickey, Burton F.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (23) : 2233 - 2247
  • [10] Development of a rapid and convenient method to purify mucins and determine their in vivo synthesis rate in rats
    Faure, M
    Moënnoz, D
    Montigon, F
    Fay, LB
    Breuillé, D
    Finot, PA
    Ballèvre, O
    Boza, J
    [J]. ANALYTICAL BIOCHEMISTRY, 2002, 307 (02) : 244 - 251